Scottish Labour's Anas Sarwar to call on UK PM Keir Starmer to resign
9th Feb 2026 13:44
(Alliance News) - Keir Starmer should quit, the leader of Scottish Labour will demand in a blow to the UK prime minister's fragile authority. Read More
(Alliance News) - Keir Starmer should quit, the leader of Scottish Labour will demand in a blow to the UK prime minister's fragile authority. Read More
(Alliance News) - Fermi Inc shares rose on Monday as it said the first six Siemens Energy AG SGT-800 natural gas turbines have arrived at private energy campus Project Matador. Read More
(Alliance News) - Devolver Digital Inc on Monday said its performance in 2025 showed an improvement over 2024, with growth in revenue and adjusted earnings. Read More
(Alliance News) - The UK financial regulator plans to publish all trading data for London-listed shares, the Financial Times reported on Monday. Read More
(Alliance News) - Stock prices in London were mixed at midday on Monday, with the blue-chip FTSE 100 paring earlier morning gains as mounting pressure on Prime Minister Keir Starmer, following senior resignations in Number 10, weighed on investor sentiment. Read More
(Alliance News) - Another key ally of Keir Starmer has quit as the UK prime minister fights for his political survival amid the fallout of the Peter Mandelson scandal. Read More
(Alliance News) - Wynnstay Group PLC on Monday proposed a higher dividend as it said it enters the new financial year with "strong operational capability and a robust balance sheet" as it posted a lower annual statutory profit and revenue. Read More
(Alliance News) - WPP PLC is in the process of a statregic overhaul, as it looks to sure up its defences against artificial intelligence. Read More
(Alliance News) - Another key ally of Keir Starmer has quit as the UK prime minister fights for his political survival amid the fallout of the Peter Mandelson scandal. Read More
(Alliance News) - The following stocks are the leading risers and fallers on AIM on Monday. Read More
(Alliance News) - Warpaint London PLC on Monday estimated a rise in 2025 sales, whilst expecting approval of its acquisition of UK cosmetics brand Barry M for GBP1.4 million. Read More
Shield Therapeutics PLC - Newcastle, England-based commercial-stage pharmaceutical company - Says the US Food & Drug Administration grants an additional three years of data exclusivity for Accrufer. The exclusivity remains in place until December 19, 2028, in addition to the Accrufer/Feraccru patent coverage valid until the mid-2030s. Read More